It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Personalized Medicine is the concept that managing a patient's health should be based on the individual patient's specific characteristics, including age, gender, height/weight, diet, environment, etc. Recent developments in genetic testing allow the development of "Genomic Personalized Medicine" and Predictive Medicine, which is the combination of comprehensive genetic testing with proactive, personalized preventive medicine. Personalized medicine is not solely about genomics, however, as personalized medicine is about you, the health consumer. Personalized medicine also allows your health care provider, such as your physician, to focus their attention on what makes you you, instead of abiding by generalities.
Many people (particularly organisations involved in genomic sequencing) are trying to transform the Personalized Medicine discussion away from the consumer and onto genomics. This has led to comments such as the following contribution in this definition: Personalized medicine the concept that information about a patient's genotype or gene expression profile could be used to further tailor medical care to an individual's needs. Such information could be used to help stratify disease status, select between different medications and/or tailor their dosage, provide a specific therapy for an individual's disease, or initiate a preventative measure that is particularly suited to that patient at the time of administration. Several examples of approaches to personalized medicine have been established in medical practice, but in general the genotype-centered approach is not yet in widespread use clinically. It is currently debated whether such "personalized medicine" offers significant advantages over traditional clinical approaches that combine an individual's personal medical history, family history, and data from imaging, laboratory, and other tests.
"Race-based medicine doesn't have any real basis in science,"
"You can look at somebody's skin colour, but it doesn't necessarily tell you much about the rest of their genome or how they'll respond to drugs or which drugs they'll respond to.’
“It is not hard to imagine the day when any discovered but non-symptomatic condition could become a ‘pre-existing condition’ for which private insurers would not pay. The eugenic implications are obvious. Thus, the growing collection of genetic test results and newborn DNA could easily enable a eugenics agenda on the part of government agencies and private industry,” it said.
In an interview at the time the dispute over newborns’ DNA in Minnesota was heating up, Brase said it’s no longer just about diabetes, asthmas and cancer.
“It’s also about behavioral issues,” she said.
“In England they decided they should have doctors looking for problem children, and have those children reported, and their DNA taken in case they would become criminals,” she said.
In fact, published reports in the U.K. note that senior police forensics experts believe genetic samples should be studied, because it may be possible to identify potential criminals as young as age 5.
“If we have a primary means of identifying people before they offend, then in the long-term the benefits of targeting younger people are extremely large,” Gary Pugh, director of forensics at Scotland Yard, was quoted saying. “You could argue the younger the better. Criminologists say some people will grow out of crime; others won’t. We have to find who are possibly going to be the biggest threat to society.”
Two decades ago, the top 10 insurers covered about 27% of all insured Americans. Today, four companies -- WellPoint Inc., UnitedHealth Group, Aetna Inc. and Cigna Corp. -- cover more than 85 million people, almost half of all those with private insurance.
A 2007 survey by the American Medical Assn. found that in two-thirds of metropolitan areas, one health insurer controlled at least 50% of the market. In the Los Angeles area, two companies dominate -- Kaiser Permanente and WellPoint's Anthem Blue Cross.
As a result, doctors and hospitals have little negotiating power and few options when an insurer rejects a bill. Some physicians are dropping out of insurance networks or turning away new patients. Others have moved to cash-only practices. Some smaller hospitals and solo-practice physicians say they are being driven out of business entirely.
The insurance industry lays much of the blame for billing problems on doctors and hospitals. Insurers question or reject claims "when we don't get full information or when we get duplicate bills," said Karen Ignagni, president of America's Health Insurance Plans, the industry's lobbying arm in Washington. "Efficiency is a two-way street."